KCNA3 and glioma: Glioma cells with a blockade of potassium channel functions through the drug temozolomide, a cytotoxic imidazotetrazine that forms O6-methylguanine, which mismatches with thymine during DNA replication, are sensitized to this drug, potentiating the antitumor effects [82].